Midazolam and Lantus drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Midazolam (midazolam) and Lantus (insulin glargine recombinant). Common drug interactions include cellulitis gangrenous among females and thrombocytopenia among males.
The phase IV clinical study analyzes what interactions people have when they take Midazolam and Lantus. It is created by eHealthMe based on reports of 89 people who take the same drugs from the FDA, and is updated regularly.
What is Midazolam?
Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.
What is Lantus?
Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.
89 people who take Midazolam and Lantus together, and have interactions are studied.

What are the common drug interactions of Midazolam and Lantus, by gender? *:
female:
- Cellulitis gangrenous (localized inflammation of the soft or connective tissue with considerable mass of body tissue dies (necrosis))
- Gangrene (body tissue dies)
- Vulvitis (inflammation of the vulva)
- Abscess (pus)
- Acute hepatic failure
- Pyrexia (fever)
- Azotaemia (excess of urea or other nitrogenous compounds in the blood)
- Blood pressure decreased
- Burkholderia test positive
- Cough
male:
- Thrombocytopenia (decrease of platelets in blood)
- Renal failure (kidney dysfunction)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Alanine aminotransferase increased
- Asthenia (weakness)
- Bacteraemia (presence of bacteria in the blood)
- Platelet count decreased
- Pneumonia bacterial (pneumonia associated with bacterial infection)
- Pyrexia (fever)
- Urinary tract infection
What are the common drug interactions of Midazolam and Lantus, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Propofol infusion syndrome
- Pyrexia (fever)
20-29:
n/a
30-39:
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Thrombocytopenia (decrease of platelets in blood)
40-49:
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
- Cellulitis (infection under the skin)
- Perineal abscess
- Anal abscess
- Vulval abscess
- Vulval cellulitis (inflammation of skin around vagina)
- Urinary tract infection
- Nerve injury
- Pain
50-59:
- Blood creatinine increased
- Bone abscess
- Cardiac arrest
- Cardiac failure
- Death
- Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
- Fibrin d dimer increased
- Fungal infection
- Gait disturbance
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
60+:
- Thrombocytopenia (decrease of platelets in blood)
- Cardiac arrest
- Agitation (state of anxiety or nervous excitement)
- Blood alkaline phosphatase increased
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Diarrhoea
- Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae)
- Escherichia infection (bacterial infection by escherichia coli)
- Hyperglycaemia (high blood sugar)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
What are the existing conditions these people have? *
- Constipation: 27 people, 30.34%
- Nausea (feeling of having an urge to vomit): 26 people, 29.21%
- Type 2 Diabetes: 24 people, 26.97%
- Sedation: 22 people, 24.72%
- High Blood Pressure: 18 people, 20.22%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 17 people, 19.10%
- Pain: 16 people, 17.98%
- Hypotension (abnormally low blood pressure): 16 people, 17.98%
- Weight Decreased: 14 people, 15.73%
- Hyperkalemia (damage to or disease of the kidney): 14 people, 15.73%
* Approximation only. Some reports may have incomplete information.
Do you take Midazolam and Lantus?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Midazolam and Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Midazolam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Midazolam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lantus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on midazolam and insulin glargine recombinant (the active ingredients of Midazolam and Lantus, respectively), and Midazolam and Lantus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Exidine and Epipen - now
- Escitalopram vs. Remeron Soltab, side effect and effectiveness comparison - 3 seconds ago
- Dry Skin and Joint Pain - 5 seconds ago
- Immunodeficiency Common Variable and Blood Pressure Fluctuation - 7 seconds ago
- Acetaminophen vs. Tizanidine Hydrochloride, side effect and effectiveness comparison - 7 seconds ago
- Could Flomax cause Dementia? - 8 seconds ago
- Infarction and drugs of ingredients of irbesartan - 14 seconds ago
- Could Copaxone cause Nausea? - 21 seconds ago
- Drug interactions of Vitamin D and Varenicline Tartrate - 27 seconds ago
- Could Promethazine Hydrochloride cause Infusion Site Erythema? - 31 seconds ago